Dr. Goldklang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
New York, NY 10032Phone+1 212-305-9876Fax+1 914-709-8165
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
- University of MichiganResidency, Internal Medicine, 2005 - 2008
- University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
- NY State Medical License 2008 - 2026
- CT State Medical License 2022 - 2025
- NJ State Medical License 2022 - 2025
- MI State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- COPD Exacerbation Blood and Urine Biomarkers Study Start of enrollment: 2018 Jun 07
Publications & Presentations
PubMed
- 1 citationsFazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).Virginia C Clark, Charlie Strange, Pavel Strnad, Antonio J Sanchez, Paul Kwo
Gastroenterology. 2024-10-01 - 1 citationsSurgical management of pleural complications in lymphangioleiomyomatosis.B Payne Stanifer, Sydney Harris, Stephanie N Nguyen, Alice V Vinogradsky, Niki Trivedi
The Journal of Thoracic and Cardiovascular Surgery. 2024-08-29 - 2 citationsBlocking RAGE expression after injury reduces inflammation in mouse model of acute lung injury.Lynne L Johnson, Yared Tekabe, Tina Zelonina, Xinran Ma, Geping Zhang
Respiratory Research. 2023-01-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: